Remarkably, NALA slightly increased cardiac EF and FS in mice under baseline conditions and significantly improved the cardiac EF and FS in Ang II-induced heart failure (Fig. 7g, h and Supplementary information, Fig. S8c, h). This evidence concerns the gene AGT and heart failure.